Obesity Surgery

, Volume 29, Issue 2, pp 451–456 | Cite as

Endoscopic Ultrasound-Directed Transgastric ERCP (EDGE): a Single-Center US Experience with Follow-up Data on Fistula Closure

  • Theodore W. James
  • Todd Huntley BaronEmail author
Original Contributions



Endoscopic ultrasound-directed transgastric ERCP (EDGE) by creating an anastomosis from the gastric pouch or jejunum to the excluded stomach allows performance of ERCP in Roux-en-Y gastric bypass (RYGB) anatomy. Concern for persistent fistula following stent removal and sparse data limit adoption.


Retrospective review of consecutive patients undergoing EDGE over a 2-year period.


Nineteen RYGB patients underwent EDGE; three had previously failed ERCP by the device-assisted method. Indications for ERCP were choledocholithiasis (8), recurrent acute pancreatitis (6), benign post-surgical stricture (3), elevated bilirubin, and papillary stenosis (1 each). EDGE was technically successful in all 19 patients with jejunogastric anastomosis in 11 patients and gastrogastric in 8 using a 15-mm lumen-apposing metal stent. Stent malposition occurred in six and was managed by rescue maneuvers. ERCP was performed in the same session in four patients; the remainder were delayed after a mean of 48 days. Diagnostic endoscopic ultrasound (EUS) was performed in four patients. No severe adverse events occurred; clinical success was 100%. Stents were removed after a mean dwell time of 182 days. Argon plasma coagulation (APC) was used to promote fistula closure in 12 patients. Upper GI series to assess fistula closure was obtained in 11 patients after a mean of 182 days following stent removal. One persistent fistula was identified and closed endoscopically.


EDGE is an effective modality for performing ERCP in patients with RYGB anatomy and can be performed via gastrogastric or jejunogastric approaches. Persistent fistula is uncommon and can be managed endoscopically. APC may promote fistula closure.


Endoscopic ultrasound Gastric bypass Roux-en-Y ERCP EDGE EUS-GG-ERCP 



Endoscopic retrograde cholangiopancreatography


Endoscopic ultrasound


Endoscopic ultrasound-directed transgastric ERCP


Device-assisted enteroscopy ERCP


Transgastric ERCP


Funding Declaration

Dr. James receives research and training support by a grant from the NIH (T32DK007634). Dr. Baron has no funding.

Compliance with Ethical Standards

Endoscopy reports, medical charts, and relevant laboratory data were reviewed and recorded in accordance with Institutional Review Board protocol. For this type of study, formal consent is not required. As this was a retrospective study of previously collected data, individual informed consent does not apply.

Conflict of Interest

Dr. Baron is a consultant and speaker for Boston Scientific, W.L. Gore, Cook Endoscopy, and Olympus America. Dr. James has no conflicts of interest.


  1. 1.
    Esteban Varela J, Nguyen NT. Laparoscopic sleeve gastrectomy leads the U.S. utilization of bariatric surgery at academic medical centers. Surg Obes Relat Dis. 2015;11(5):987–90.CrossRefGoogle Scholar
  2. 2.
    Shiffman ML, Sugerman HJ, Kellum JM, et al. Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol. 1991;86(8):1000–5.Google Scholar
  3. 3.
    Nagem RG, Lázaro-da-Silva A, de Oliveira RM, et al. Gallstone-related complications after roux-en-y gastric bypass: a prospective study. Hepatobiliary Pancreat Dis Int. 2012;11(6):630–5.CrossRefGoogle Scholar
  4. 4.
    Banerjee N, Parepally M, Byrne TK, et al. Systematic review of transgastric ERCP in Roux-en-Y gastric bypass patients. Surg Obes Relat Dis. 2017;13(7):1236–42.CrossRefGoogle Scholar
  5. 5.
    Skinner M, Popa D, Neumann H, et al. ERCP with the overtube-assisted enteroscopy technique: a systematic review. Endoscopy. 2014;46(7):560–72.CrossRefGoogle Scholar
  6. 6.
    Inamdar S, Slattery E, Sejpal DV, et al. Systematic review and meta-analysis of single-balloon enteroscopy-assisted ERCP in patients with surgically altered GI anatomy. Gastrointest Endosc. 2015;82(1):9–19.CrossRefGoogle Scholar
  7. 7.
    Kedia P, Sharaiha RZ, Kumta NA, et al. Internal EUS-directed transgastric ERCP (EDGE): game over. Gastroenterology. 2014;147(3):566–8.CrossRefGoogle Scholar
  8. 8.
    Tyberg A, Nieto J, Salgado S, et al. Endoscopic ultrasound (EUS)-directed transgastric endoscopic retrograde cholangiopancreatography or EUS: mid-term analysis of an emerging procedure. Clin Endosc. 2017;50(2):185–90.CrossRefGoogle Scholar
  9. 9.
    Jirapinyo P, Thompson AC, Kröner PT, et al. Metabolic effect of foregut exclusion demonstrated by the impact of gastrogastric fistula on recurrence of diabetes. J Am Coll Surg. December 2017;Google Scholar
  10. 10.
    Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010;71(3):446–54.CrossRefGoogle Scholar
  11. 11.
    Crismale JF, Riff BP, Schwartz M, et al. Closure of an iatrogenic gastrogastric fistula created during EUS-directed transgastric ERCP. VideoGIE. 2016;1(3):61–2.CrossRefPubMedCentralGoogle Scholar
  12. 12.
    Ngamruengphong S, Nieto J, Kunda R, et al. Endoscopic ultrasound-guided creation of a transgastric fistula for the management of hepatobiliary disease in patients with Roux-en-Y gastric bypass. Endoscopy. 2017;49(6):549–52.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Gastroenterology and HepatologyUniversity of North CarolinaChapel HillUSA

Personalised recommendations